Bladder Cancer

Cancer Research UK. Bladder cancer statistics for the UK, www.info.cancerresearchuk.org/cancerstats/mortality/; 2011 [accessed 10/05/2011].

Lynch CF , Cohen MB . Urinary system. Cancer 1995; 75 (Suppl.): 316.

Blandy J , Fowler C. Bladder tumours. In: Urology. 2nd ed. Oxford: Blackwell Science; 1997 p. 289.

Sylvester RJ , van der Meijden AP , Oosterlinck W , Witjes JA , Bouffioux C , Denis L , Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 2006; 49 (3): 466–75.

Prout GR Jr , Griffin PP , Shipley WU . Bladder carcinoma as a systemic disease. Cancer 1979; 43 (June (6)): 2532–9.

Idris BI , Giskes K , Borrell C , Benach J , Costa G , Federico B , Higher smoking prevalence in urban compared to non-urban areas: time trends in six European countries. Health Place 2007; 13 (3): 702–12.

Silverman DT , Hartge P , Morrison AS . Epidemiology of bladder cancer. Haematol Oncol Clin North Am 1992; 6: 1–30.

Lilienfeld AM , Levin ML , Moore GE . The association of smoking with cancer of the urinary bladder in humans. Arch Int Med 1956; 98: 129–35.

Fleschner N , Kondylis F. Demographics and epidemiology of urothelial cancer of the urinary bladder. In: Droller MJ , editor. Urothelial tumours. Hamilton, Ontario: Decker; 2004. p. 1–16.

Duncan RE , Bennet DW , Evans AT . Radiation induced bladder tumours. J Urol 1977; 188: 43–5.

Nieder AM , Porter MP , Soloway MS . Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study. J Urol 2008; 180 (November (5)): 2005–9.

Aben KK , Kiemeney LA . Epidemiology of bladder cancer. Eur Urol 1999; 36: 660–72.

Gouda I , Mokhtar N , Bilal D , El-Bolkainy T , El-Bolkainy NM . Bilharziasis and bladder cancer: a time trend analysis of 9843 patients. J Egypt Natl Canc Inst 2007; 19 (June (2)): 158–62.

Edwards TJ , Dickinson AJ , Natale S , Gosling J , McGrath JS . A prospective analysis of the diagnostic yield resulting from the attendance of 4020 patients at a protocol-driven haematuria clinic. BJU Int 2006; 97 (2): 301–5.

Palou J , Rodriguez-Rubio F Huguet J , Segarra J , Ribal MJ , Villavicencio H , Multivariate analysis of clinical parameters of synchronous primary superficial bladder cancer and upper urinary tract tumours. J Urol 2005; 174 (September (3)): 859–61.

Bastacky S , Ibrahim S , Wilczynski SP , Murphy WM . The accuracy of urinary cytology in daily practice. Cancer 1999; 87 (3): 118–28.

Mowatt G , Zhu S , Kilonzo M , Boachie C , Fraser C , Griffiths TR , Systematic review of the clinical effectiveness and costeffectiveness of photodynamic diagnosis and urine biomarkers (FISH, ImmunoCyt NMP22) and cytology for the detection and follow-up of bladder cancer. Health Technol Assess 2010; 14 (January (4)): 1–331.

Witjes JA , Redorta JP , Jacqmin D , Sofras F , Malmström PU , Riedl C , Hexaminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: review of the evidence and recommendations. Eur Urol 2010; 57 (April (4)): 607–14.

Miladi M , Peyromaure M , Zerbib M , Saïghi D , Debré B. The value of a second transurethral resection in evaluating patients with bladder tumours. Eur Urol 2003; 3 (March (3)): 241–5.

Mostofi F. Histological typing of urinary bladder tumours. Geneva: World Health Organisation; 1973.

Sauter G , Algaba F Amin M , Busch C , Cheville J , Gasser T et al. Tumours of the urinary system: non-invasive urothelial neoplasias. In: Eble JN , Sauter G , Epstein Jl , Sesterhenn I , editors. WHO classification of classification of tumors of the urinary system and male genital organs. Lyon: IARC Press; 2004. p. 29–34.

Oosterlinck W , Sylvester R , Kaasinen E , Böhle A , Palou-Redorta J , Rouprět M. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 Update. Babjuk M. Eur Urol 2011; 59 (June (6)): 997–1008.

Herr HW , Badalament RA , Amato DA , Laudone VP , Fair WR , Whitmore WF Jr . Superficial bladder cancer treated with bacillus Calmette-Guerin: a multivariate analysis of factors affecting tumour progression. J Urol 1989; 141: 22–9.

Allard P , Bernard P , Fradet Y Tetu B. The early clinical course of primary Ta and T1 bladder cancer: a proposed prognostic index. Br J Urol 1998; 81: 692–8.

Sylvester RJ , van der Meijden AP , Oosterlinck W , Witjes JA , Bouffioux C , Denis L , Predicting recurrence and progression in individual patients with stage TaT1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 2006; 9 (March (3)): 466–75.

Melamed MR , Grabstald H , Whitmore WF . Carcinoma in situ of the bladder: clinico-pathological study of case with a suggested approach to detection. J Urol 1966; 96: 466–71.

Hudson MA , Herr HW . Carcinoma in situ of the bladder. J Urol 1995; 153: 564–72.

Zein TA , Milad MF . Urine cytology in bladder tumors. Int Surg 1991; 76 (1): 52–4.

Lamm DL . Carcinoma in situ. Urol Clin North Am 1992; 19: 499–508.

Herr HW , Schwalb DM , Zhang ZF , Sogani PC , Fair WR , Whitmore WF Jr , Intravesical bacillus Calmette-Guerin therapy prevents tumour progression and death from superficial bladder cancer: ten year follow up of a prospective randomised trial. J Clin Oncol 1995; 13: 1404–8.

Wolf H , Melsen F , Pedersen SE , Neilson KT . Natural history of carcinoma in situ of the urinary bladder. Scand J Urol Nephrol Suppl 1994; 157: 147–51.

Utz DC , Farrow GM . Management of carcinoma in situ of the bladder: the case for surgical management. Urol Clin North Am 1980; 7: 533–41.

Sylvester RJ , Oosterlinck W , van der Meijden AP . A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a metaanalysis of published results of randomized clinical trials. J Urol 2004; 171 (June (6 Pt 1)): 2186–90.

Oddens JR , van der Meijden AP , Sylvester R. One immediate postoperative instillation of chemotherapy in low risk Ta T1 bladder cancer patients. Is it always safe?. Eur Urol 2004; 46 (September (3)): 336–8.

Sylvester RJ , Oosterlinck W , Witjes JA . The schedule and duration of intravesical chemotherapy in patients with non muscle invasive bladder cancer: a systematic review of the published results of randomized clinical trials Eur Urol 2008; 53 (April (4)): 709–19.

Shintani Y , Sawada Y Inagaki T Kohjimoto Y , Uekado Y Shinka T Intravesical instillation therapy with bacillus Calmette-Guérin for superficial bladder cancer: study of the mechanism of bacillus Calmette-Guérin immunotherapy. Int J Urol 2007; 14 (2): 140–6.

Sylvester RJ , van der Meijden AP , Lamm DL . Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials. J Urol 2002; 168 (November (5)): 1964–70.

EORTC trial 30911: van der Meijden A, Oosterlinck W, Brausi M, Kurth K-H, Sylvester R, deBalincourt C, Members of the EORTC-GU Group Superficial Bladder Committee a: significance of bladder biopsies in Ta,T1 bladder tumors: a report from the EORTC Genito-Urinary Tract Cancer Cooperative Group. Eur Urol 1999; 35: 267–71.

Duque JLF , Loughlin KR . An overview of the treatment of superficial bladder cancer. Intravesical therapy. Urol Clin North Am 2000; 27 (1): 125–35.

Raj GV , Herr H , Serio AM , Donat SM , Bochner BH , Vickers AJ , Treatment paradigm shift may improve survival of patients with high risk superficial bladder cancer. J Urol 2007; 177 (April (4)): 1283–6.

Chade DC , Laudone VP , Bochner BH , Parra RO . Oncological outcomes after radical cystectomy for bladder cancer: open versus minimally invasive approaches. J Urol 2010; 183 (March (3)): 862–9.

Bassi P , Ferrante GD , Piazza N , Spinadin R , Carando R , Pappagallo G , Prognostic factors of outcome after radical cystectomy for bladder cancer: a retrospective study of a homogeneous patient cohort. J Urol 1999; 161 (5): 1494–7.

Stein JP , Lieskovsky G , Cote R , Groshen S , Feng AC , Boyd S , Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 2001; 19 (3): 666–75.

Samuel JD , Bhatt RI , Montague RJ , Clarke NW , Ramani VA . The natural history of postoperative renal function in patients undergoing ileal conduit diversion for cancer measured using serial isotopic glomerular filtration rate and 99m technetium-mercaptoacetyltriglycine renography. J Urol 2006; 176 (6 Pt 1): 2518–22.

Kock NG , Nilson AE , Nilsson LO , Norlen LJ , Philipson BM . Urinary diversion via a continent ileal reservoir: clinical results in 12 patients. J Urol 1982; 128: 469–75.

Lampel A , Fisch M , Stein R , Schultz-Lampel D , Hohenfellner M , Eggersmann C , Continent diversion with the Mainz pouch. World J Urol 1996; 14 (2): 85–91.

Ghoneim MA , Kock NG , Kycke G , El-Din AB Shehab . An appliance free sphincter controlled bladder substitute: the urethral Kock pouch. J Urol 1987; 138: 1150–4.

Hautmann RE , Miller K , Steiner U , Wenderoth U. The ileal neobladder: 6 years of experience with more than 200 patients. J Urol 1993; 150: 40–5.

Stein JP , Cote RJ , Freeman JA , Esrig D , Elmajian DA , Groshen S , Indications for lower urinary tract reconstruction in women after cystectomy for bladder cancer: a pathological review of female cystectomy specimens. J Urol 1995; 154: 1329–33.

Studer U , Danuser H , Merz V , Springer J , Zingg EJ . Experience in 100 patients with an ileal low pressure bladder substitute combined with an efferent tubular isoperistaltic segment. J Urol 1995; 154: 49–56.

Studer UE , Burkhard FC , Schumacher M , Kessler TM , Thoeny H , Fleischmann A , Twenty years experience with an ileal orthotopic low pressure bladder substitute—lessons to be learned. J Urol 2006; 176 (July (1)): 161–6.

Blandy JP , England HR , Evans SJW , Hope-Stone HF , Mair GMM , Mantell BS , T3 bladder cancer—the case for Salvage Cystectomy. Br J Urol 1980; 52: 506–10.

Kent E , Sandler H , Montie J , Lee C , Herman J , Esper P , Combined-modality therapy with gemcitabine and radiotherapy as a bladder preservation strategy: results of a phase I trial. J Clin Oncol 2004; 22 (July (13)): 2540–5.

Shelley MD , Barber J , Wilt T Mason MD . Surgery versus radiotherapy for muscle invasive bladder cancer. Cochrane Database Syst Rev 2002; 1: CD002079.

Piet AH , Hulshof MC , Pieters BR , Pos FJ , de Reijke TM , Koning CC . Clinical Results of a concomitant boost radiotherapy technique for muscle-invasive bladder cancer. Strahlenther Onkol 2008; 184 (June (6)): 313–8.

International Collaboration of Trialists on behalf of the Medical Research Council Advanced Bladder Cancer Working Party (now the National Cancer Research Institute Bladder Cancer Clinical Studies Group), the European Organisation for Research and Treatment of Cancer GenitoUrinary Tract Cancer Group, the Australian Bladder Cancer Study Group, the National Cancer Institute of Canada Clinical Trials Group, Finnbladder, Norwegian Bladder Cancer Study Group, and Club Urologico Espanol de Tratamiento Oncologico Group: international phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial. J Clin Oncol. doi:10.1200/JCO.2010.32.3139.

Grossman HB , Natale RB , Tangen CM , Speights VO , Vogelzang NJ , Trump DL , Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 2003; 349: 859–66.

Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data. Eur Urol 2005; 48 (August (2)). p. 189–199; discussion 199–201.

Donat SM . Integrating perioperative chemotherapy into the treatment of muscle-invasive bladder cancer: strategy versus reality. J Natl Compr Canc Netw 2009; 7: 40–7.

Stenzl A , Cowan NC , De Santis M , Kuczyk MA , Merseburger AS , Ribal MJ , Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines. Eur Urol 2011; 59 (June (6)): 1009–18.